Salem Capital Management Inc Amgen Inc Transaction History

Salem Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 13, 2021	SELL	$233.58 - $259.14 $256,938 - $285,054	-1,100 Closed	0 $0
Q2 2018 Jul 09, 2018	BUY	$166.05 - $186.51 $182,655 - $205,161	1,100 New	1,100 $203,000
Q4 2017 Jan 16, 2018	SELL	$168.79 - $188.59 $202,548 - $226,308	-1,200 Closed	0 $0
Q3 2017 Oct 10, 2017	BUY	$167.29 - $191.0 $200,748 - $229,200	1,200	1,200 $224,000

2,969

401M

6.59M

6.61M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $178B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Salem Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Salem Capital Management Inc with notifications on news.